Organogenesis Holdings Inc (ORGO)

12:20 PM

Organogenesis rises as PuraPlyAM succeeds in diabetic foot ulcers - MSN

12:20 PM

May 25, 2026

ORGO stock rallies after hours on clearing regulatory pathway for pain relief treatment - MSN

May 25, 2026

May 20, 2026

Organogenesis Holdings stock (US68620V1026): BTIG rating cut puts focus on outlook after Q1 update - AD HOC NEWS

May 20, 2026

May 20, 2026

Is Organogenesis Holdings Inc. (ORGO) Losing Momentum? BTIG Pulls Buy Rating After Q1 Update - Insider Monkey

May 20, 2026

May 20, 2026

Organogenesis outlines 2025 revenue guidance of $500M–$525M as CMS policy shift drives growth outlook - MSN

May 20, 2026

May 17, 2026

Organogenesis shares jump 20% following positive clinical trial results - MSN

May 17, 2026

May 17, 2026

Organogenesis Holdings stock (US68620V1026): FDA warning letter and Nasdaq notice put focus on compl - AD HOC NEWS

May 17, 2026

May 14, 2026

Organogenesis Holdings stock (US68620V1026): shares react to earnings and outlook update - AD HOC NEWS

May 14, 2026

May 14, 2026

Organogenesis Holdings Inc.Class A (NQ: ORGO - FinancialContent

May 14, 2026

May 12, 2026

Organogenesis Holdings stock (US68620V1026): Q1 earnings miss on revenue and EPS - AD HOC NEWS

May 12, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 09, 2026

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2026 Earnings Call Transcript - Insider Monkey

May 09, 2026

May 08, 2026

RI skin-maker Organogenesis reports steep Q1 loss amid CMS policy change - The Business Journals

May 08, 2026

May 08, 2026

Organogenesis (ORGO) Q1 2026 Earnings Transcript - AOL.com

May 08, 2026

May 08, 2026

BTIG downgrades Organogenesis stock rating to neutral on reimbursement headwinds By Investing.com - Investing.com South Africa

May 08, 2026

May 08, 2026

BTIG Downgrades Organogenesis(ORGO.US) to Hold Rating - Moomoo

May 08, 2026

May 08, 2026

Organogenesis forecasts $270M-$310M 2026 revenue amid prolonged CMS-related recovery - MSN

May 08, 2026

May 08, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 08, 2026

May 08, 2026

Organogenesis Holdings Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 08, 2026

May 08, 2026

Organogenesis Q1 Earnings Call Highlights - Barchart.com

May 08, 2026

May 08, 2026

BTIG downgrades Organogenesis stock rating to neutral on reimbursement headwinds - Investing.com UK

May 08, 2026

May 08, 2026

Organogenesis Holdings Inc. (ORGO) Stock Report: Exploring A Potential 216% Upside - DirectorsTalk Interviews

May 08, 2026

May 08, 2026

Skin Substitute Market Is Going to Boom Rapidly |Organogenesis - openPR.com

May 08, 2026

May 07, 2026

Earnings call transcript: Organogenesis Q1 2026 earnings miss and stock reacts By Investing.com - Investing.com South Africa

May 07, 2026

May 07, 2026

Earnings call transcript: Organogenesis Q1 2026 earnings miss and stock reacts - Investing.com Australia

May 07, 2026

May 07, 2026

Organogenesis : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

May 07, 2026

May 07, 2026

Organogenesis Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2026

May 07, 2026

Organogenesis: Q1 Earnings Snapshot - Barchart.com

May 07, 2026

May 07, 2026

ORGO: Revenue fell 58% and net loss widened sharply in Q1 2026 amid regulatory disruption - TradingView

May 07, 2026

May 07, 2026

Organogenesis posts $53M loss as wound-care sales drop 63% - Stock Titan

May 07, 2026

May 07, 2026

[10-Q] Organogenesis Holdings Inc. Quarterly Earnings Report - Stock Titan

May 07, 2026

May 07, 2026

Organogenesis (NASDAQ: ORGO) posts 58% Q1 revenue drop and deeper loss - Stock Titan

May 07, 2026

May 05, 2026

Credit Suisse reiterated coverage on Organogenesis Holdings with a new price target - Quantisnow

May 05, 2026

May 05, 2026

U.S. Perinatal Tissue-derived Allograft Market Detailed In New - openPR.com

May 05, 2026

May 01, 2026

ORGO Price Today: Organogenesis Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

May 01, 2026

Apr 30, 2026

[ARS] Organogenesis Holdings Inc. SEC Filing - Stock Titan

Apr 30, 2026

Apr 30, 2026

Organogenesis (NASDAQ: ORGO) details 2026 virtual meeting, pay and audit votes - Stock Titan

Apr 30, 2026

Apr 30, 2026

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® - Orthopedics This Week

Apr 30, 2026

Apr 30, 2026

Organogenesis (ORGO) Projected to Post Earnings on Thursday - MarketBeat

Apr 30, 2026

Apr 29, 2026

Organogenesis completes biologics license application for knee OA By Investing.com - Investing.com India

Apr 29, 2026

Apr 29, 2026

Organogenesis completes biologics license application for knee OA - Investing.com UK

Apr 29, 2026

Apr 28, 2026

Organogenesis Holdings Inc. Completes Biologics License Application Submission for ReNu® to Treat Knee Osteoarthritis - Quiver Quantitative

Apr 28, 2026

Apr 28, 2026

What's going on with Organogenesis stock on Wednesday? - MSN

Apr 28, 2026

Apr 28, 2026

Organogenesis (NASDAQ:ORGO) Trading Up 1.7%Time to Buy? - MarketBeat

Apr 28, 2026